Cargando…
High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy
BACKGROUND: HBV-resistant mutants in treatment-naïve patients may lead to antiviral treatment failure. It is not clear if HBV mutants are present in pregnant women and about the influence of the preexisting mutants on the short-term antiviral therapy during pregnancy. METHOD: We enrolled 73 pregnant...
Autores principales: | Wang, Jing, Liu, Jinfeng, Yu, Qiang, Jin, Li, Yao, Naijuan, Yang, Yuan, Yan, Taotao, Hu, Chunhua, He, Yingli, Zhao, Yingren, Chen, Tianyan, Zheng, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079218/ https://www.ncbi.nlm.nih.gov/pubmed/33986897 http://dx.doi.org/10.1155/2021/6653546 |
Ejemplares similares
-
Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis
por: Wu, Yuchao, et al.
Publicado: (2020) -
Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China
por: Chen, Tianyan, et al.
Publicado: (2018) -
Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression
por: Zhang, Yu, et al.
Publicado: (2016) -
Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents
por: Yan, Taotao, et al.
Publicado: (2019) -
Incidence of mother‐to‐child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta‐analysis
por: Yao, Naijuan, et al.
Publicado: (2022)